Brain-type creatine kinase BB as a potential tumour marker—Serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies
- 1 October 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (10) , 951-956
- https://doi.org/10.1016/0277-5379(82)90243-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Creatine kinase isozymes in human tumorsBiochemical and Biophysical Research Communications, 1981
- Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.Clinical Chemistry, 1980
- Radioimmunoassay of serum creatine kinase BB as index of brain damage after head injury.BMJ, 1980
- RADIOIMMUNOASSAY OF SERUM CREATINE KINASE-BB AS A TUMOUR MARKER IN BREAST CANCERThe Lancet, 1980
- Radioimmunoassay of brain-type creatine kinase-BB isoenzyme in human tissues and in serum of patients with neurological disordersJournal of the Neurological Sciences, 1980
- Creatine kinase BB: a new tumor-associated marker.Clinical Chemistry, 1979
- Serum creatine kinase isoenzyme BB as an indicator of active metastatic disease.Clinical Chemistry, 1979
- Radioimmunoassay of creatine kinase isoenzymes in human serum: isoenzyme BB.Clinical Chemistry, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977